These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20214524)

  • 1. Neoadjuvant therapy preceding prostatectomy for prostate cancer: rationale and current trials.
    Sonpavde G; Palapattu GS
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):439-50. PubMed ID: 20214524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
    Sonpavde G; Chi KN; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Berry WR; Kadmon D
    Cancer; 2007 Dec; 110(12):2628-39. PubMed ID: 17941029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant systemic therapy for urological malignancies.
    Sonpavde G; Sternberg CN
    BJU Int; 2010 Jul; 106(1):6-22. PubMed ID: 20553475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant docetaxel treatment for locally advanced prostate cancer: a clinicopathologic study.
    Magi-Galluzzi C; Zhou M; Reuther AM; Dreicer R; Klein EA
    Cancer; 2007 Sep; 110(6):1248-54. PubMed ID: 17674353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.
    Kim WY; Whang YE; Pruthi RS; Baggstrom MQ; Rathmell WK; Rosenman JG; Wallen EM; Goyal LK; Grigson G; Watkins C; Godley PA
    Urol Oncol; 2011; 29(6):608-13. PubMed ID: 20022268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patients.
    Womble PR; VanVeldhuizen PJ; Nisbet AA; Reed GA; Thrasher JB; Holzbeierlein JM
    J Urol; 2011 Sep; 186(3):882-7. PubMed ID: 21791342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoadjuvant androgen deprivation preceding to radical prostatectomy--its role in short-term and long-term outcomes].
    Homma Y
    Nihon Rinsho; 1998 Aug; 56(8):2162-6. PubMed ID: 9750527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemohormonal therapy in poor-prognosis localized prostate cancer.
    Sella A; Zisman A; Kovel S; Yarom N; Leibovici D; Lindner A
    Urology; 2008 Feb; 71(2):323-7. PubMed ID: 18308112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer.
    Chi KN; Chin JL; Winquist E; Klotz L; Saad F; Gleave ME
    J Urol; 2008 Aug; 180(2):565-70; discussion 570. PubMed ID: 18554663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
    Koontz BF; Moul J
    Cancer; 2008 Jun; 112(11):2518-9; author reply 2519. PubMed ID: 18338760
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer.
    Cha EK; Eastham JA
    Urol Oncol; 2015 May; 33(5):217-25. PubMed ID: 25596644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoadjuvant therapy of prostate carcinoma].
    Ebert T
    Praxis (Bern 1994); 1997 Nov; 86(46):1815-8. PubMed ID: 9454282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.
    Wood DP; Beaman A; Banerjee M; Powell I; Pontes E; Cher ML
    Clin Cancer Res; 1998 Sep; 4(9):2119-23. PubMed ID: 9748128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New development of endocrine therapy in prostate cancer].
    Naito S
    Gan To Kagaku Ryoho; 1996 May; 23(6):684-8. PubMed ID: 8645018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints.
    Oh WK
    Urol Oncol; 2003; 21(3):229-34. PubMed ID: 12810211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Chemotherapy Using Reduced-Dose Docetaxel Followed by Radical Prostatectomy for Patients With Intermediate and High-Risk Prostate Cancer: A Single-Center Study.
    Nosov A; Reva S; Petrov S; Mamijev E; Novikov R; Veliev E; Imkamp F; Tolkach Y; Moiseenko V
    Prostate; 2016 Nov; 76(15):1345-52. PubMed ID: 26864707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer.
    Febbo PG; Richie JP; George DJ; Loda M; Manola J; Shankar S; Barnes AS; Tempany C; Catalona W; Kantoff PW; Oh WK
    Clin Cancer Res; 2005 Jul; 11(14):5233-40. PubMed ID: 16033841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomy.
    Andriole GL
    Eur Urol; 1997; 32 Suppl 3():65-9. PubMed ID: 9267788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant therapy prior to radiotherapy for clinically localized prostate cancer.
    Roach M
    Eur Urol; 1997; 32 Suppl 3():48-54. PubMed ID: 9267785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.